MiMedx Group, Inc. (MDXG)
4.50
-0.01
(-0.22%)
USD |
NASDAQ |
Aug 28, 16:00
4.49
-0.01
(-0.22%)
After-Hours: 20:00
MiMedx Group Free Cash Flow : 42.33M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 42.33M |
| March 31, 2026 | 67.22M |
| December 31, 2025 | 70.88M |
| September 30, 2025 | 67.87M |
| June 30, 2025 | 58.47M |
| March 31, 2025 | 65.64M |
| December 31, 2024 | 64.48M |
| September 30, 2024 | 54.64M |
| June 30, 2024 | 47.05M |
| March 31, 2024 | 33.08M |
| December 31, 2023 | 24.62M |
| September 30, 2023 | 7.511M |
| June 30, 2023 | -4.046M |
| March 31, 2023 | -14.91M |
| December 31, 2022 | -20.58M |
| September 30, 2022 | -16.79M |
| June 30, 2022 | -11.66M |
| March 31, 2022 | -7.074M |
| December 31, 2021 | -5.452M |
| September 30, 2021 | -14.45M |
| June 30, 2021 | -25.49M |
| March 31, 2021 | -30.22M |
| December 31, 2020 | -34.82M |
| September 30, 2020 | -46.19M |
| June 30, 2020 | -44.30M |
| Date | Value |
|---|---|
| March 31, 2020 | -38.92M |
| December 31, 2019 | -41.63M |
| September 30, 2019 | -18.14M |
| June 30, 2019 | -13.80M |
| March 31, 2019 | 2.617M |
| December 31, 2018 | 25.77M |
| September 30, 2018 | 45.81M |
| June 30, 2018 | 61.45M |
| March 31, 2018 | 54.94M |
| December 31, 2017 | 57.54M |
| September 30, 2017 | 53.39M |
| June 30, 2017 | 37.90M |
| March 31, 2017 | 31.49M |
| December 31, 2016 | 18.69M |
| September 30, 2016 | 5.674M |
| June 30, 2016 | 10.06M |
| March 31, 2016 | 6.335M |
| December 31, 2015 | 12.13M |
| September 30, 2015 | 17.12M |
| June 30, 2015 | 19.74M |
| March 31, 2015 | 18.56M |
| December 31, 2014 | 13.65M |
| September 30, 2014 | 6.559M |
| June 30, 2014 | -0.7438M |
| March 31, 2014 | -2.857M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Anika Therapeutics, Inc. | 0.562M |
| Perspective Therapeutics, Inc. | -121.38M |
| ABVC BioPharma, Inc. | -2.697M |
| Enovis Corp. | 63.66M |
| Edwards Lifesciences Corp. | 1.434B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.03M |
| Cash from Investing (Quarterly) | -0.635M |
| Cash from Financing (Quarterly) | -13.27M |
| Free Cash Flow Per Share (Quarterly) | -0.0722 |
| Free Cash Flow to Equity (Quarterly) | -10.28M |
| Free Cash Flow to Firm (Quarterly) | -10.34M |
| Free Cash Flow Yield | 6.31% |